Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03198364 · ClinicalTrials.gov registry record · NA
Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI
A NA study of Schizophrenia and Bipolar Disorder, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
- 1
- Study location
NCT03198364: Completed NA study of Schizophrenia and Bipolar Disorder, sponsored by University of California, San Diego.
NCT03198364 is a NA study of Schizophrenia and Bipolar Disorder that has completed, run by University of California, San Diego. The registered enrollment target is 78 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03198364, a NA study of Schizophrenia and Bipolar Disorder, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
- 1
- Study location
Study Summary
Schizophrenia and bipolar disorder are associated with high risk for suicide, yet there are few brief interventions that directly target suicide prevention in this large population. The goal of this intervention development study is to evaluate the feasibility, acceptability, and preliminary effectiveness of a brief intervention called SafeTy and Recovery Therapy (START) that is augmented with content delivered on mobile devices outside of the clinic setting. The intervention will evaluated in a community urgent care center context as people initiate outpatient care, and, if effective, could be deployed in a wide network of such centers.
Primary Outcome
21 Item clinician rated scale
Conditions Studied
Interventions
- BEHAVIORAL Safety and Recovery Therapy
- BEHAVIORAL Mobile Augmentation
Study Locations (1)
California
- University of California, San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2018-03-01 |
| Est. Completion | 2021-06-30 |
| Phase | NA |
What the finished NCT03198364 record still lists
NCT03198364 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (64% lower).
The record links to 3 conditions, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Safety and Recovery Therapy is the first listed.
NCT03198364 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03198364 about?
NCT03198364 is a clinical study titled "Development of a Mobile Heath Augmented Brief Suicide Prevention Intervention for People With SMI". Schizophrenia and bipolar disorder are associated with high risk for suicide, yet there are few brief interventions that directly target suicide prevention in this large population. The goal of this intervention development study is to evaluate the feasibility, acceptability, and preliminary effecti...
What is the current status of trial NCT03198364?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2018-03-01. Estimated completion is 2021-06-30.
What conditions does trial NCT03198364 study?
This clinical trial studies the following conditions: Schizophrenia, Bipolar Disorder, Suicide and Self-harm.
What interventions are being tested in trial NCT03198364?
The interventions under investigation include: Safety and Recovery Therapy (BEHAVIORAL), Mobile Augmentation (BEHAVIORAL).
Who is sponsoring clinical trial NCT03198364?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03198364 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Schizophrenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03198364's enrollment target sits among peer trials
78 166th of 315 higher than 150 of 315 other Schizophrenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Schizophrenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Taking Action for College Students
RECRUITING · NA
-
Enhancing Prefrontal Oscillations and Working Memory in Early-course Schizophrenia
RECRUITING · NA
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Enhancing Brain Connectivity in Schizophrenia Through Neuromodulation (Study 1)
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
TMS for Inhibition Enhancement in Schizophrenia
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI